Deutsche Bank’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,600
| Closed | -$19K | – | 5254 |
|
|
2019
Q3 | $19K | Buy |
6,600
+6,200
| +1,550% | +$12.7K | ﹤0.01% | 4354 |
|
|
2019
Q2 | $0 | Buy |
+400
| New | +$818 | ﹤0.01% | 5651 |
|
|
2018
Q1 | – | Sell |
-10,718
| Closed | -$34K | – | 5729 |
|
|
2017
Q4 | $34K | Buy |
+10,718
| New | +$93.7K | ﹤0.01% | 4556 |
|
|
2016
Q3 | – | Sell |
-1,219
| Closed | -$21K | – | 5349 |
|
|
2016
Q2 | $21K | Buy |
1,219
+667
| +121% | +$20.8K | ﹤0.01% | 4743 |
|
|
2016
Q1 | $20K | Buy |
552
+123
| +29% | +$4.91K | ﹤0.01% | 4641 |
|
|
2015
Q4 | $28K | Sell |
429
-51
| -11% | -$3.66K | ﹤0.01% | 4647 |
|
|
2015
Q3 | $27K | Buy |
480
+87
| +22% | +$7.7K | ﹤0.01% | 4688 |
|
|
2015
Q2 | $31K | Buy |
+393
| New | +$26.4K | ﹤0.01% | 4770 |
|
|
2014
Q4 | – | Sell |
-124
| Closed | -$5K | – | 6417 |
|
|
2014
Q3 | $5K | Sell |
124
-496
| -80% | -$23.2K | ﹤0.01% | 5545 |
|
|
2014
Q2 | $37K | Sell |
620
-10
| -2% | -$558 | ﹤0.01% | 5071 |
|
|
2014
Q1 | $48K | Buy |
630
+329
| +109% | +$25.5K | ﹤0.01% | 4571 |
|
|
2013
Q4 | $18K | Sell |
301
-8,166
| -96% | -$475K | ﹤0.01% | 4768 |
|
|
2013
Q3 | $555K | Buy |
8,467
+7,797
| +1,164% | +$630K | ﹤0.01% | 3408 |
|
|
2013
Q2 | $60K | Buy |
+670
| New | +$55.4K | ﹤0.01% | 4444 |
|
Deutsche Bank's FCSC Position: Q4 2019 in Review
Deutsche Bank sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 6,600 shares — an estimated $19K sold.
Deutsche Bank first reported a position in FCSC in Q2 2013 and held it in 14 quarters. The position peaked at $555K in Q3 2013. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Deutsche Bank reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Deutsche Bank sold 6,600 Fibrocell Science Inc. shares in Q4 2019, an estimated $19K.
- Deutsche Bank first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 14 quarters.
- Deutsche Bank's Fibrocell Science Inc. position peaked at $555K in Q3 2013.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.